Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus ...

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later ...

Artisan Select Equity Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: "Elevance Health, Inc. (NYSE:ELV) took a couple of blows this quarter.

Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4. Upfront premiums collected by health insurers lead to reliable revenue ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Wednesday reported fourth-quarter profit of $856 million. On a per-share basis, the Indianapolis-based company said it had ...

Elevance Health executives told investors on Thursday morning that they're confident in their 7% to 9% growth targets in Medicare Advantage based on early data coming out of the annual enrollment ...

Elevance Health is putting a focus on growth at its Carelon subsidiary as it heads into 2023. Carelon includes multiple arms of the company, including its Carelon Rx pharmacy benefit manager ...

Hotchkis & Wiley Large Cap Fundamental Value Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: "Elevance Health, Inc. (NYSE:ELV) is a large ...

Since 2018, Elevance Health has achieved a compound annual growth ... materially more than I think the company has ever seen in Q4. Just curious, given the MLR was generally in line.